Transitions

Transitions Magazine

Transitions is published bi-monthly for members of the APhA New Practitioner Network. The online newsletter contains information focused on life inside and outside pharmacy practice, providing guidance on various areas of professional, personal, and practice development. Each issue includes in-depth articles on such topics as personal financial management, innovative practice sites, career profiles, career development tools, residency and postgraduate programs, and more.

New report finds growth in illegal online pharmacies

Monday, June 5, 2023 0 9432

A new report from IQVIA Institute for Human Data Science estimates that of 7,310 prescription drugs legally dispensed to U.S. patients between January 2017 to December 2022, roughly 70% (5,085) were being actively marketed and sold by illegal online pharmacies.

Most Americans more likely to seek non-emergency health care at pharmacies

Wednesday, May 31, 2023 0 14420

A new survey from Wolters Kluwer Health reflects increasing trust in providers in non-traditional primary care settings.

FDA approves new buprenorphine treatment option for OUD

FDA has approved buprenorphine extended-release injection (Brixadi—Braeburn) for the treatment of moderate to severe opioid use disorder...

To protect infants, FDA advisers recommend RSV vaccine during pregnancy

Members of an FDA advisory panel voted in support of Pfizer’s respiratory syncytial virus (RSV) vaccine (Abrysvo) for the prevention of RSV...

Study finds OUD med underprescribed, especially by race

Findings from a study published in NEJM suggest that a key treatment for opioid use disorder is underprescribed among patients in the United...

FDA announces updates to warning for all prescription stimulants

To prevent misuse, abuse, and addiction of prescription stimulants, FDA is now requiring their boxed warning—the most prominent...

CDC identifies first-ever drug-resistant ringworm in U.S.

CDC reported that two cases of drug-resistant ringworm infections involving the fungus Trichophyton indotineae were identified in New York City,...

Friday, May 5, 2023

DEA announces extension for telemedicine prescribing of certain drugs

DEA has said that for now it is extending emergency telehealth policies set during the COVID-19 pandemic, enabling certain health care providers to have greater leeway in prescribing some controlled substances.

Thursday, May 4, 2023

FDA approves RSV vaccine for older adults

FDA approved GSK’s respiratory syncytial virus (RSV) vaccine (Arexvy) for adults aged 60 years and older.

First Previous 8 9 10 11 12 13 14 15 16 17 Next Last

Tags:

Publications Transitions

Transitions Magazine

New report finds growth in illegal online pharmacies

Most Americans more likely to seek non-emergency health care at pharmacies

FDA approves new buprenorphine treatment option for OUD

FDA approves new buprenorphine treatment option for OUD

To protect infants, FDA advisers recommend RSV vaccine during pregnancy

Study finds OUD med underprescribed, especially by race

FDA announces updates to warning for all prescription stimulants

CDC identifies first-ever drug-resistant ringworm in U.S.

DEA announces extension for telemedicine prescribing of certain drugs

FDA approves RSV vaccine for older adults

Tags: